PharmMD is a leading healthcare technology company providing data-driven medication adherence platform solutions that deliver value-based care outcomes. Founded in 2006, PharmMD helps healthcare organizations and customers make better use of prescription medicines through their predictive analytics platform and targeted clinical programs. PharmMD provides proprietary protocols and personalized patient medication management therapy solutions used by health plans, self-insured employers, and accountable care organizations (ACOs) to improve drug therapy outcomes, increase Star ratings, and lower the cost of healthcare. Since its founding, PharmMD has been tackling the $300B + annual cost of medication underuse, overuse, and misuse. To date, their largest customers are health plans focusing predominantly on Medicare Part C & D subscribers. PharmMD is backed by the Riverside Company, Clayton Associates, and FCA Venture Partners.